ARTICLE | Company News
Intra-Cellular, Takeda in schizophrenia deal
March 3, 2011 1:54 AM UTC
Intra-Cellular Therapies Inc. (New York, N.Y.) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) partnered to develop and commercialize Intra-Cellular's preclinical phosphodiesterase-1 (PDE-1) inhibitor...